Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/23 18:08 | 2/24/23 | RUBY | Health | BioPrd | Biological Products, (No Diag | Appelhans Dannielle | MA | O | CEO,P | S | -1 | 0.1274 | 0 | -10 | -100 | 0 | D | ||||||||||||||
2/1/23 21:41 | 2/1/23 | RUBY | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | S | -2 | 0.2500 | 0 | -8 | -11 | 66 | D | |||||||||||||||
2/1/23 21:40 | 2/1/23 | RUBY | Health | BioPrd | Biological Products, (No Diag | Appelhans Dannielle | MA | O | CEO,P | S.d | -1 | 0.2500 | 0 | -4 | -27 | 10 | D | ||||||||||||||
1/31/23 21:51 | 1/31/23 | RUBY | Health | BioPrd | Biological Products, (No Diag | Cagnoni Pablo J | MA | D | S.d | -2 | 0.2410 | 0 | -7 | -9 | 75 | D | |||||||||||||||
1/31/23 21:50 | 1/31/23 | RUBY | Health | BioPrd | Biological Products, (No Diag | Turka Laurence A. | MA | O | Chief Sc | S.d | -1 | 0.2400 | 0 | -3 | -12 | 18 | D | ||||||||||||||
8/12/22 15:06 | 8/10/22 | RUBY | Health | BioPrd | Biological Products, (No Diag | Appelhans Dannielle | MA | O | COO | S.d | -5 | 0.8000 | 0 | -6 | -46 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |